Request for Letters of Interest (LOI) for NCI-ComboMATCH Laboratories; Extension of Submission Period

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published

October 3, 2023

Issuing agencies

Health and Human Services DepartmentNational Institutes of Health

Abstract

The Department of Health and Human Services, National Institutes of Health (NIH) published a Notice in the Federal Register on August 14, 2023. This document extends the date to submit Letters of Interest (LOIs) to the National Cancer Institute (NCI), NIH.

Full Text

<html>
<head>
<title>Federal Register, Volume 88 Issue 190 (Tuesday, October 3, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 190 (Tuesday, October 3, 2023)]
[Notices]
[Page 68123]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-21758]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Request for Letters of Interest (LOI) for NCI-ComboMATCH 
Laboratories; Extension of Submission Period

AGENCY: National Institutes of Health, HHS.

ACTION: Notice; extension of submission period.

-----------------------------------------------------------------------

SUMMARY: The Department of Health and Human Services, National 
Institutes of Health (NIH) published a Notice in the Federal Register 
on August 14, 2023. This document extends the date to submit Letters of 
Interest (LOIs) to the National Cancer Institute (NCI), NIH.

DATES: The deadline to submit LOIs for NCI-ComboMATCH Laboratories, 
which published at 88 FR 55055 on August 14, 2023, is extended. LOIs 
should be submitted before 5 p.m. EST on October 31, 2023.

FOR FURTHER INFORMATION CONTACT: Questions about this request for LOIs 
should be directed to <a href="/cdn-cgi/l/email-protection#e0aea3a9a3afada2afada1b4a3a8ac8182a1909093a08e8988ce878f96"><span class="__cf_email__" data-cfemail="cd838e848e82808f82808c998e8581acaf8cbdbdbe8da3a4a5e3aaa2bb">[email&#160;protected]</span></a> or Benjamin Kim at 
<a href="/cdn-cgi/l/email-protection#1371767d79727e7a7d3d787a7e537d7a7b3d747c65"><span class="__cf_email__" data-cfemail="0361666d69626e6a6d2d686a6e436d6a6b2d646c75">[email&#160;protected]</span></a> or by phone at (240) 276-5961.

SUPPLEMENTARY INFORMATION: On August 14, 2023, NIH published a notice 
in the Federal Register, FR Doc. 2023-17352, on pages 55055-55057. This 
notice extends the submission date for LOIs from September 30, 2023, to 
October 31, 2023.

Lyndsay N. Harris,
Associate Director, Cancer Diagnosis Program, Division of Cancer 
Treatment & Diagnosis, National Cancer Institute.
[FR Doc. 2023-21758 Filed 10-2-23; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>

View on FederalRegister.gov →Plain-text source

Indexed from Federal Register on October 3, 2023.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.